HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 2.7
Author: MarketBeat

→ Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at HC Wainwright. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by HC Wainwright.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
SGMO Sangamo Therapeutics	$0.58 +2.2%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 5/15/2024
CLDX Celldex Therapeutics	$40.71 +3.1%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$80.00	Low	View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 5/15/2024
DARE Daré Bioscience	$0.34 +7.9%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 5/15/2024
GNFT Genfit	$3.78 +2.4%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 5/15/2024
TLPH Talphera	$1.22 +19.1%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 5/15/2024
DRRX DURECT	$0.92	5/15/2024	Reiterated by	HC Wainwright	-	Neutral		Low	View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 5/15/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
PDSB PDS Biotechnology	$3.70 +4.5%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	Low	View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 5/15/2024
LQDA Liquidia	$12.00 +0.3%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 5/15/2024
DPRO Draganfly	$0.30 -2.4%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$1.00	Low	View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 5/15/2024
PGEN Precigen	$1.44 +5.1%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 5/15/2024
OCGN Ocugen	$1.90 +11.5%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 5/15/2024
ABSI Absci	$4.84 +0.2%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 5/15/2024
DCTH Delcath Systems	$7.54 +6.6%	5/15/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$20.00 -> $22.00	Low	View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 5/15/2024
IPHA Innate Pharma	$2.54 -3.8%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.50	Low	View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 5/15/2024
SYRS Syros Pharmaceuticals	$5.46 +0.6%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Syros Pharmaceuticals (NASDAQ:SYRS) on 5/15/2024
SCPH scPharmaceuticals	$4.67 +3.8%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 5/15/2024
FENC Fennec Pharmaceuticals	$7.12 -3.0%	5/15/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$18.00 -> $15.00	Low	View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 5/15/2024
GANX Gain Therapeutics	$2.52 +7.7%	5/15/2024	Reiterated by	HC Wainwright	Analyst R. Selvaraju	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 5/15/2024
ABOS Acumen Pharmaceuticals	$3.89 +5.4%	5/15/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 5/15/2024
FF First Mining Gold	C$0.16	5/14/2024	Target Raised by	HC Wainwright	-		C$0.70 -> C$0.80	N/A	View details for HC Wainwright rating of First Mining Gold (TSE:FF) on 5/14/2024
EMX EMX Royalty	$1.90 +0.5%	5/14/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$6.50 -> $6.75	N/A	View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 5/14/2024
DRD DRDGOLD	$8.84 +2.4%	5/14/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$13.25 -> $15.50	Low	View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 5/14/2024
PPTA Perpetua Resources	$5.57 +0.4%	5/14/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$10.50 -> $13.25	Low	View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 5/14/2024
BTM Bitcoin Depot	$1.92 +3.0%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 5/14/2024
ACRV Acrivon Therapeutics	$8.60 +2.9%	5/14/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$20.00 -> $22.00	Low	View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 5/14/2024
UNCY Unicycive Therapeutics	$1.08 -0.9%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.50	Low	View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/14/2024
MITK Mitek Systems	$14.10 +1.9%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 5/14/2024
IDN Intellicheck	$2.94 -2.0%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 5/14/2024
FLUX Flux Power	$3.52 +4.1%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Flux Power (NASDAQ:FLUX) on 5/14/2024
FF FutureFuel	$4.97	5/14/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$0.70 -> $0.80	Low	View details for HC Wainwright rating of FutureFuel (NYSE:FF) on 5/14/2024
IVVD Invivyd	$2.52 +3.7%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 5/14/2024
CMPX Compass Therapeutics	$1.63 +0.9%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 5/14/2024
LIFE aTyr Pharma	$1.97 +8.1%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$35.00	Low	View details for HC Wainwright rating of aTyr Pharma (NASDAQ:LIFE) on 5/14/2024
CRDL Cardiol Therapeutics	$2.27 +4.1%	5/14/2024	Reiterated by	HC Wainwright	Analyst V. Bernardino	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 5/14/2024
INKT MiNK Therapeutics	$1.04 -7.4%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 5/14/2024
PLUG Plug Power	$3.40 -1.2%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 5/14/2024
APRE Aprea Therapeutics	$5.74 -2.5%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 5/14/2024
TRML Tourmaline Bio	$15.42 +6.9%	5/14/2024	Reiterated by	HC Wainwright	Analyst Y. Chen	Buy -> Buy	$48.00	Low	View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 5/14/2024
KURA Kura Oncology	$21.70 +3.8%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 5/14/2024
SPRB Spruce Biosciences	$0.81 -2.3%	5/14/2024	Reiterated by	HC Wainwright	Analyst R. Selvaraju	Neutral		Low	View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 5/14/2024
He cracked the code to crypto… (Ad) Juan Villaverde has cracked the code to crypto. Click now for the best way into the newest AI projects
URGN UroGen Pharma	$13.84 +6.7%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$54.00	Low	View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 5/14/2024
COCP Cocrystal Pharma	$2.10 +12.1%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 5/14/2024
AADI Aadi Bioscience	$1.93 +2.4%	5/14/2024	Reiterated by	HC Wainwright	Analyst R. Burns	Neutral		Low	View details for HC Wainwright rating of Aadi Bioscience (NASDAQ:AADI) on 5/14/2024
TERN Terns Pharmaceuticals	$5.82 -2.8%	5/14/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$5.50	Low	View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 5/14/2024
PMVP PMV Pharmaceuticals	$2.19 +2.3%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 5/14/2024
ITRM Iterum Therapeutics	$1.50 -0.3%	5/14/2024	Reiterated by	HC Wainwright	Analyst E. Arce	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 5/14/2024
RPHM Reneo Pharmaceuticals	$1.61 -0.6%	5/14/2024	Reiterated by	HC Wainwright	Analyst M. Kapoor	Neutral -> Neutral	$1.50	Low	View details for HC Wainwright rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 5/14/2024
IMNN Imunon	$1.37 +1.9%	5/14/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$13.00 -> $12.00	Low	View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 5/14/2024
VRCA Verrica Pharmaceuticals	$9.51 +0.2%	5/14/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$13.00 -> $14.00	Low	View details for HC Wainwright rating of Verrica Pharmaceuticals (NASDAQ:VRCA) on 5/14/2024
ANNX Annexon	$4.61 -4.4%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 5/14/2024
FULC Fulcrum Therapeutics	$8.59 +8.6%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	Low	View details for HC Wainwright rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/14/2024
CALC CalciMedica	$5.60 +0.9%	5/14/2024	Reiterated by	HC Wainwright	Analyst J. Pantginis	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 5/14/2024
CYTK Cytokinetics	$59.92 +0.9%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$94.00	Low	View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 5/14/2024
STRO Sutro Biopharma	$4.27 -1.6%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 5/14/2024
INSM Insmed	$26.16 +2.8%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$52.00	Low	View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 5/14/2024
TCRX TScan Therapeutics	$9.08 +1.0%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 5/14/2024
CAPR Capricor Therapeutics	$5.26 +1.2%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/14/2024
TBPH Theravance Biopharma	$9.78 +4.2%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Theravance Biopharma (NASDAQ:TBPH) on 5/14/2024
PRAX Praxis Precision Medicines	$45.97 +0.2%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$105.00	Low	View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/14/2024
LPTX Leap Therapeutics	$2.82 +2.5%	5/14/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$7.00 -> $5.50	Low	View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 5/14/2024
ALT Altimmune	$8.34 +6.6%	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 5/14/2024
ONCY Oncolytics Biotech	$1.18	5/14/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 5/14/2024
ACLX Arcellx	$53.15 +5.0%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$82.00 -> $80.00	Low	View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 5/13/2024
YMAB Y-mAbs Therapeutics	$12.49 +5.7%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$21.00 -> $22.00	Low	View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 5/13/2024
GNLX Genelux	$3.88 +8.4%	5/13/2024	Reiterated by	HC Wainwright	Analyst E. Bodnar	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 5/13/2024
CRBU Caribou Biosciences	$3.73 +2.5%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$24.00	Low	View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 5/13/2024
NKTX Nkarta	$7.17 +9.5%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$22.00 -> $23.00	N/A	View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 5/13/2024
MGNX MacroGenics	$4.57 +2.7%	5/13/2024	Target Lowered by	HC Wainwright	Analyst R. Burns	Neutral -> Neutral	$16.00 -> $4.00	Low	View details for HC Wainwright rating of MacroGenics (NASDAQ:MGNX) on 5/13/2024
RVNC Revance Therapeutics	$3.42 -1.7%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$12.00 -> $11.00	Low	View details for HC Wainwright rating of Revance Therapeutics (NASDAQ:RVNC) on 5/13/2024
BTDR Bitdeer Technologies Group	$5.56 +3.3%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 5/13/2024
ATOS Atossa Therapeutics	$1.65 +6.8%	5/13/2024	Target Raised by	HC Wainwright	Analyst E. Bodnar	Buy -> Buy	$4.00 -> $6.00	Low	View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 5/13/2024
ARWR Arrowhead Pharmaceuticals	$24.72 +7.9%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$90.00	Low	View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/13/2024
VRNA Verona Pharma	$13.98 +0.7%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$33.00 -> $30.00	Low	View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 5/13/2024
NGNE Neurogene	$33.13 +5.0%	5/13/2024	Target Lowered by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$55.00 -> $51.00	Low	View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 5/13/2024
TIL Instil Bio	$12.23 +2.9%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	N/A	View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 5/13/2024
ANIP ANI Pharmaceuticals	$66.16 +0.2%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$83.00 -> $87.00	Low	View details for HC Wainwright rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 5/13/2024
TARS Tarsus Pharmaceuticals	$39.08 +2.9%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$57.00 -> $61.00	Low	View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/13/2024
INAB IN8bio	$1.05 +1.0%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$14.00 -> $12.50	Low	View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 5/13/2024
CMPS COMPASS Pathways	$8.26 +1.1%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$120.00	Low	View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 5/13/2024
VERU Veru	$1.49 +1.0%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 5/13/2024
MUX McEwen Mining	$10.64 -0.6%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$13.00 -> $15.00	Low	View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 5/13/2024
GNTA Genenta Science	$3.20 -0.6%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Genenta Science (NASDAQ:GNTA) on 5/13/2024
NVAX Novavax	$12.12 -10.1%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Novavax (NASDAQ:NVAX) on 5/13/2024
CLMT Calumet Specialty Products Partners	$15.21 -1.6%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 5/13/2024
SOUN SoundHound AI	$5.22 -1.5%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 5/13/2024
FTCI FTC Solar	$0.51 -0.8%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$1.50	Low	View details for HC Wainwright rating of FTC Solar (NASDAQ:FTCI) on 5/13/2024
RVMD Revolution Medicines	$39.79 +6.4%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$44.00	Low	View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 5/13/2024
COGT Cogent Biosciences	$7.75 +5.4%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 5/13/2024
OMGA Omega Therapeutics	$2.26 -4.2%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Omega Therapeutics (NASDAQ:OMGA) on 5/13/2024
SVRA Savara	$4.93 +2.5%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 5/13/2024
Top 5 AI Stocks to Buy for 2024 (Ad) 5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist. Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
AKRO Akero Therapeutics	$21.19 +4.4%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 5/13/2024
FDMT 4D Molecular Therapeutics	$25.80 +0.2%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$36.00	Low	View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 5/13/2024
OCUP Ocuphire Pharma	$1.72 +1.2%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Ocuphire Pharma (NASDAQ:OCUP) on 5/13/2024
CLSD Clearside Biomedical	$1.33 +3.9%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$6.00 -> $5.00	Low	View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 5/13/2024
EYPT EyePoint Pharmaceuticals	$13.03 +4.7%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$33.00 -> $30.00	Low	View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/13/2024
VSTM Verastem	$13.48 +2.4%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.50	Low	View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 5/13/2024
GRTS Gritstone bio	$0.76 -0.8%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$7.00 -> $4.00	Low	View details for HC Wainwright rating of Gritstone bio (NASDAQ:GRTS) on 5/13/2024
SRTS Sensus Healthcare	$5.82 +9.8%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$8.00 -> $10.00	Low	View details for HC Wainwright rating of Sensus Healthcare (NASDAQ:SRTS) on 5/13/2024
CODX Co-Diagnostics	$1.14 +1.8%	5/13/2024	Target Lowered by	HC Wainwright	-	Neutral -> Neutral	$2.50 -> $2.00	Low	View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 5/13/2024
OCS Oculis	$12.05 -0.9%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$28.00 -> $28.00	Low	View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 5/13/2024
ITOS iTeos Therapeutics	$17.87 +6.9%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$44.00 -> $46.00	Low	View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 5/13/2024
JANX Janux Therapeutics	$48.55 +1.3%	5/13/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$50.00 -> $63.00	Low	View details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 5/13/2024
RICK RCI Hospitality	$47.97 +1.5%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$115.00 -> $98.00	Low	View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 5/13/2024
ANVS Annovis Bio	$8.83 +5.6%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$30.00 -> $23.00	Low	View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 5/13/2024
BHVN Biohaven	$38.28 +2.8%	5/13/2024	Target Lowered by	HC Wainwright	Analyst D. Tsao	Buy -> Buy	$63.00 -> $59.00	Low	View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 5/13/2024
ENTX Entera Bio	$2.68 +6.8%	5/13/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 5/13/2024
ONCT Oncternal Therapeutics	$8.44 -2.1%	5/13/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$28.00 -> $19.00	Low	View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 5/13/2024
CBUS Cibus	$18.77 -1.2%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 5/10/2024
WPRT Westport Fuel Systems	$6.09 -0.2%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$30.00 -> $22.00	Low	View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 5/10/2024
MOGO Mogo	$1.69 -0.6%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 5/10/2024
AMTX Aemetis	$4.14 +1.5%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$28.00	Low	View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 5/10/2024
EXK Endeavour Silver	$3.51 +5.4%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.25	Low	View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 5/10/2024
CLSK CleanSpark	$15.96 +3.9%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 5/10/2024
TPST Tempest Therapeutics	$3.42 +0.6%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$47.00	Low	View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 5/10/2024
ATXS Astria Therapeutics	$9.73 +2.5%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$16.00	Low	View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 5/10/2024
MARA Marathon Digital	$18.81 +4.1%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$35.00 -> $27.00	Low	View details for HC Wainwright rating of Marathon Digital (NASDAQ:MARA) on 5/10/2024
IOVA Iovance Biotherapeutics	$10.83 +1.0%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/10/2024
MNPR Monopar Therapeutics	$0.67 +2.3%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$2.00	Low	View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 5/10/2024
IRON Disc Medicine	$32.09 +0.8%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$70.00	Low	View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 5/10/2024
ARGX argenx	$375.27 +5.4%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$451.00 -> $448.00	Low	View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 5/10/2024
CHRS Coherus BioSciences	$2.19 +5.3%	5/10/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$11.00 -> $12.00	Low	View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 5/10/2024
MNMD Mind Medicine (MindMed)	$8.90 +4.8%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$75.00 -> $35.00	Low	View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/10/2024
CRNX Crinetics Pharmaceuticals	$50.44 +2.1%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$60.00	Low	View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 5/10/2024
PHAT Phathom Pharmaceuticals	$10.41 +0.2%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$28.00	Low	View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 5/10/2024
LFMD LifeMD	$8.56 -5.7%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 5/10/2024
LPTH LightPath Technologies	$1.40 +4.2%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 5/10/2024
QSI Quantum-Si	$1.88 +3.0%	5/10/2024	Reiterated by	HC Wainwright	Analyst S. Ramakanth	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 5/10/2024
RLYB Rallybio	$1.83 -0.8%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 5/10/2024
TYRA Tyra Biosciences	$18.61 +0.2%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$23.00	Low	View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 5/10/2024
IPSC Century Therapeutics	$3.20 +1.6%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$13.00 -> $11.00	Low	View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 5/10/2024
CARM Carisma Therapeutics	$1.45 -0.7%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$9.00 -> $8.00	Low	View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 5/10/2024
AVXL Anavex Life Sciences	$4.49 +4.2%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 5/10/2024
KZR Kezar Life Sciences	$0.79 +0.5%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 5/10/2024
BTAI BioXcel Therapeutics	$2.11 -0.9%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 5/10/2024
ADMA ADMA Biologics	$9.14 -0.2%	5/10/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$7.50 -> $10.00	Low	View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 5/10/2024
ETNB 89bio	$9.56 +5.2%	5/10/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$31.00 -> $29.00	Low	View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 5/10/2024
CPRX Catalyst Pharmaceuticals	$16.98 +3.0%	5/10/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$24.00 -> $26.00	Low	View details for HC Wainwright rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 5/10/2024
PRQR ProQR Therapeutics	$1.98 -0.3%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/10/2024
AMLX Amylyx Pharmaceuticals	$1.89 +1.1%	5/10/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 5/10/2024
ADVM Adverum Biotechnologies	$8.80 -1.5%	5/10/2024	Reiterated by	HC Wainwright	Analyst M. Caufield	Buy -> Buy	$30.00	N/A	View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 5/10/2024
Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad) The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016. Get the full story here.
HLVX HilleVax	$14.60 +11.2%	5/10/2024	Reiterated by	HC Wainwright	Analyst M. Caufield	Buy -> Buy	$28.00	N/A	View details for HC Wainwright rating of HilleVax (NASDAQ:HLVX) on 5/10/2024
ACAD ACADIA Pharmaceuticals	$15.28 +2.8%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$33.00 -> $27.00	Low	View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/9/2024
VERV Verve Therapeutics	$6.41 +2.9%	5/9/2024	Reiterated by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 5/9/2024
LEGN Legend Biotech	$45.15 +1.7%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$87.00 -> $87.00	Low	View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 5/9/2024
VCEL Vericel	$49.95 +2.9%	5/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$53.00 -> $55.00	Low	View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 5/9/2024
PTGX Protagonist Therapeutics	$31.62 +6.8%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$38.00	Low	View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/9/2024
VRDN Viridian Therapeutics	$14.51 -1.1%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$37.00 -> $27.00	Low	View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 5/9/2024
SANA Sana Biotechnology	$9.00 +4.7%	5/9/2024	Reiterated by	HC Wainwright	Analyst E. Bodnar	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 5/9/2024
RNAC Cartesian Therapeutics	$27.39 +10.7%	5/9/2024	Reiterated by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$54.00	Low	View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/9/2024
AVDL Avadel Pharmaceuticals	$15.81 -1.9%	5/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$25.00 -> $27.00	Low	View details for HC Wainwright rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 5/9/2024
CNTX Context Therapeutics	$1.73 +1.3%	5/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.00 -> $5.00	Low	View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 5/9/2024
OLMA Olema Pharmaceuticals	$10.37 +2.0%	5/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$25.00 -> $28.00	Low	View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 5/9/2024
PDSB PDS Biotechnology	$3.70 +4.5%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	Low	View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 5/9/2024
FEMY Femasys	$1.36 -1.4%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$13.00	Low	View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 5/9/2024
IMCR Immunocore	$55.96 +0.2%	5/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$90.00 -> $100.00	Low	View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 5/9/2024
SLRN Acelyrin	$4.92 +4.0%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$28.00 -> $18.00	Low	View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 5/9/2024
PRTA Prothena	$21.98 +6.3%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$90.00 -> $84.00	Low	View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 5/9/2024
ALEC Alector	$5.60 +5.1%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$41.00 -> $35.00	Low	View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 5/9/2024
CTMX CytomX Therapeutics	$2.00 +3.1%	5/9/2024	Reiterated by	HC Wainwright	-	Neutral		Low	View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/9/2024
BKSY BlackSky Technology	$1.18 +0.4%	5/9/2024	Reiterated by	HC Wainwright	Analyst S. Buck	Buy -> Buy	$2.50	Low	View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 5/9/2024
FTEK Fuel Tech	$1.20 -0.8%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of Fuel Tech (NASDAQ:FTEK) on 5/9/2024
ASM Avino Silver & Gold Mines	$0.87 +6.5%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$1.60 -> $1.50	Low	View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/9/2024
ASM Avino Silver & Gold Mines	$0.90 +3.5%	5/9/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$1.60 -> $1.50	Low	View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/9/2024
AG First Majestic Silver	$7.43 +2.1%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.50	Low	View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 5/9/2024
HL Hecla Mining	$5.50 +1.9%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.25	Low	View details for HC Wainwright rating of Hecla Mining (NYSE:HL) on 5/9/2024
MIRM Mirum Pharmaceuticals	$24.98 +0.7%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$58.00	Low	View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/9/2024
DVAX Dynavax Technologies	$11.04 +0.4%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$29.00	Low	View details for HC Wainwright rating of Dynavax Technologies (NASDAQ:DVAX) on 5/9/2024
IFRX InflaRx	$1.41 -1.4%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 5/9/2024
KPTI Karyopharm Therapeutics	$1.13 +3.7%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 5/9/2024
SNDX Syndax Pharmaceuticals	$21.99 +1.5%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$41.00	Low	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 5/9/2024
AVBP ArriVent BioPharma	$19.28 +4.4%	5/9/2024	Reiterated by	HC Wainwright	Analyst R. Burns	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 5/9/2024
TNGX Tango Therapeutics	$7.81 +2.8%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	Low	View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 5/9/2024
BWAY BrainsWay	$5.48	5/9/2024	Target Raised by	HC Wainwright	Analyst B. Pachaiyappan	Buy -> Buy	$13.00 -> $15.00	Low	View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 5/9/2024
AQST Aquestive Therapeutics	$3.27 +2.2%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/9/2024
PYPD PolyPid	$4.33 -0.5%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 5/9/2024
CDXC ChromaDex	$3.73 +1.9%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of ChromaDex (NASDAQ:CDXC) on 5/9/2024
MRUS Merus	$45.55 +1.7%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$65.00	Low	View details for HC Wainwright rating of Merus (NASDAQ:MRUS) on 5/9/2024
MYO Myomo	$3.65 +2.0%	5/9/2024	Reiterated by	HC Wainwright	Analyst S. Lee	Buy -> Buy	$6.50	N/A	View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 5/9/2024
KMDA Kamada	$5.57 -1.6%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 5/9/2024
ERAS Erasca	$1.96 +5.4%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 5/9/2024
KROS Keros Therapeutics	$54.16 +2.6%	5/9/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$100.00	Low	View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 5/9/2024
NVCT Nuvectis Pharma	$6.34 -6.4%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	Low	View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 5/8/2024
QURE uniQure	$5.06 +3.1%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 5/8/2024
APLS Apellis Pharmaceuticals	$42.37 +2.8%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$92.00	Low	View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 5/8/2024
EOLS Evolus	$13.24 +3.7%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 5/8/2024
APLM Apollomics	$0.35 -1.8%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$5.00 -> $2.00	Low	View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 5/8/2024
MLTX MoonLake Immunotherapeutics	$41.00 +0.6%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$100.00	Low	View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 5/8/2024
OCUL Ocular Therapeutix	$6.29 +4.0%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$16.00 -> $14.00	Low	View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 5/8/2024
DBVT DBV Technologies	$0.60 +1.8%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $5.00	Low	View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 5/8/2024
ZNTL Zentalis Pharmaceuticals	$12.12 +3.9%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$46.00 -> $40.00	Low	View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 5/8/2024
He cracked the code to crypto… (Ad) Juan Villaverde has cracked the code to crypto. Click now for the best way into the newest AI projects
PCRX Pacira BioSciences	$30.71 -0.4%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$57.00	Low	View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 5/8/2024
PTN Palatin Technologies	$2.07 -14.1%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	N/A	View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 5/8/2024
MDGL Madrigal Pharmaceuticals	$212.12 +0.5%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$425.00 -> $390.00	Low	View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 5/8/2024
CLNN Clene	$0.39 +1.5%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 5/8/2024
CYTK Cytokinetics	$59.92 +0.9%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$94.00	Low	View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 5/8/2024
DNLI Denali Therapeutics	$20.45 +3.5%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$95.00	Low	View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 5/8/2024
OPK OPKO Health	$1.32 +1.1%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 5/8/2024
ESPR Esperion Therapeutics	$2.23 +2.3%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$16.00	Low	View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 5/8/2024
ARMP Armata Pharmaceuticals	$2.77 -5.1%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	N/A	View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 5/8/2024
RIGL Rigel Pharmaceuticals	$0.97 +2.7%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 5/8/2024
SRRK Scholar Rock	$14.18 +1.2%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 5/8/2024
VIGL Vigil Neuroscience	$3.50 -4.4%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$24.00	Low	View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/8/2024
ARVN Arvinas	$33.44 +6.6%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$87.00	Low	View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 5/8/2024
URG Ur-Energy	$1.77 +0.9%	5/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$3.40 -> $3.30	N/A	View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 5/8/2024
VALN Valneva	$8.65 +8.0%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$26.00	Low	View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 5/8/2024
CRIS Curis	$14.55 -7.3%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$26.00	Low	View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 5/8/2024
LGND Ligand Pharmaceuticals	$86.44 +1.3%	5/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$144.00	Low	View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/8/2024
BNTX BioNTech	$92.50 +0.2%	5/8/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$107.00 -> $113.00	Low	View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 5/8/2024
GHRS GH Research	$13.10 +0.6%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/7/2024
ENTA Enanta Pharmaceuticals	$13.71 +3.5%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$28.00 -> $27.00	Low	View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 5/7/2024
CIFR Cipher Mining	$3.85 +3.8%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.50 -> $5.50	Low	View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 5/7/2024
AGEN Agenus	$10.70	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 5/7/2024
TVTX Travere Therapeutics	$7.07 +5.5%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 5/7/2024
MRNS Marinus Pharmaceuticals	$1.41 +5.4%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$27.00 -> $11.00	Low	View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 5/7/2024
ELDN Eledon Pharmaceuticals	$2.37 +1.3%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$13.00 -> $16.00	Low	View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 5/7/2024
LBPH Longboard Pharmaceuticals	$21.22 +4.3%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$60.00	Low	View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/7/2024
STOK Stoke Therapeutics	$14.71 +14.9%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$35.00	Low	View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 5/7/2024
ALTO Alto Ingredients	$1.78 +0.3%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.50	Low	View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 5/7/2024
HALO Halozyme Therapeutics	$45.27 +3.3%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 5/7/2024
BCRX BioCryst Pharmaceuticals	$6.44 +20.1%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2024
PLRX Pliant Therapeutics	$16.15 +14.2%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$36.00	Low	View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024
ZYME Zymeworks	$9.12 +1.3%	5/7/2024	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$10.00	Low	View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 5/7/2024
ADCT ADC Therapeutics	$4.32 +6.9%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$9.00 -> $8.00	Low	View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 5/7/2024
AXSM Axsome Therapeutics	$77.07 -0.3%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$190.00	Low	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/7/2024
RANI Rani Therapeutics	$5.71 -1.2%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$12.00 -> $13.00	Low	View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 5/7/2024
LYEL Lyell Immunopharma	$2.62 +3.1%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 5/7/2024
FHTX Foghorn Therapeutics	$5.74 +1.2%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/7/2024
DAWN Day One Biopharmaceuticals	$16.94 +1.9%	5/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$50.00 -> $40.00	Low	View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 5/7/2024
CLDX Celldex Therapeutics	$40.71 +3.1%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$80.00	Low	View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 5/7/2024
CTSO Cytosorbents	$0.84 +0.9%	5/7/2024	Reiterated by	HC Wainwright	Analyst S. Lee	Neutral -> Neutral	$1.00	Low	View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 5/7/2024
GAU Galiano Gold	$1.71 -0.2%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.30 -> $4.40	N/A	View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 5/7/2024
VIR Vir Biotechnology	$10.01 -0.7%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$110.00	Low	View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 5/7/2024
ALNY Alnylam Pharmaceuticals	$148.52 +0.4%	5/7/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$395.00 -> $400.00	Low	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/7/2024
VRTX Vertex Pharmaceuticals	$435.65 +1.6%	5/7/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$462.00	Low	View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/7/2024
MGX Metagenomi	$6.70 +2.4%	5/7/2024	Initiated by	HC Wainwright	Analyst M. Kapoor	Buy	$10.00	Low	View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 5/7/2024
LYRA Lyra Therapeutics	$0.36 -1.9%	5/7/2024	Downgraded by	HC Wainwright	Analyst M. Caufield	Buy -> Neutral	$12.00 -> $2.00	Low	View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/7/2024
KRYS Krystal Biotech	$166.84 +4.6%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$200.00	Low	View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/6/2024
GLYC GlycoMimetics	$0.28 +0.8%	5/6/2024	Reiterated by	HC Wainwright	Analyst E. White	Buy -> Neutral		N/A	View details for HC Wainwright rating of GlycoMimetics (NASDAQ:GLYC) on 5/6/2024
RGLS Regulus Therapeutics	$2.01 -3.4%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 5/6/2024
GOSS Gossamer Bio	$0.74 +0.9%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 5/6/2024
LCTX Lineage Cell Therapeutics	$1.11 +6.7%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	N/A	View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 5/6/2024
VYNE VYNE Therapeutics	$2.87 -0.7%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.75	Low	View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 5/6/2024
VERU Veru	$1.49 +1.0%	5/6/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$2.00 -> $3.00	Low	View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 5/6/2024
URGN UroGen Pharma	$13.84 +6.7%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$54.00	Low	View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 5/6/2024
NR Newpark Resources	$7.64 +1.1%	5/6/2024	Reiterated by	HC Wainwright	Analyst A. Dayal	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Newpark Resources (NYSE:NR) on 5/6/2024
CRDF Cardiff Oncology	$3.62 +1.1%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 5/6/2024
BCPC Balchem	$156.69 +0.9%	5/6/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$167.00 -> $170.00	Low	View details for HC Wainwright rating of Balchem (NASDAQ:BCPC) on 5/6/2024
SAND Sandstorm Gold	$5.68 +1.4%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Sandstorm Gold (NYSE:SAND) on 5/6/2024
SWTX SpringWorks Therapeutics	$45.32 +5.5%	5/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$74.00	Low	View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 5/6/2024
ALDX Aldeyra Therapeutics	$4.32 +3.6%	5/6/2024	Reiterated by	HC Wainwright	Analyst M. Caufield	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024

MarketBeat Community Rating for HC Wainwright

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		25,224 (Vote Outperform)
Underperform Votes:		21,934 (Vote Underperform)
Total Votes:		47,158

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

HC Wainwright Analyst Recommendations & Stock Picks

MarketBeat Community Rating for HC Wainwright

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info